Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphodiesterase type IV inhibitors

M N Palfreyman1, J E Souness

  • 1Rhône-Poulence Rorer Central Research, Dagenham Research Centre, Essex, U.K.

Progress in Medicinal Chemistry
|January 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential of phosphodiesterase type of IV inhibitors in the treatment of rheumatoid arthritis.

IDrugs : the investigational drugs journal·2008
Same author

Potential of p38 inhibitors in the treatment of rheumatoid arthritis.

Drug news & perspectives·2003
Same author

RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency.

Bioorganic & medicinal chemistry letters·2001
Same author

The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy.

Bioorganic & medicinal chemistry·2001
Same author

A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects.

Pulmonary pharmacology & therapeutics·2000
Same author

Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors.

Immunopharmacology·2000